MML Investors Services
VKTX icon

MML Investors Services’s Viking Therapeutics VKTX Stock Holding History

MML Investors Services’s Portfolio VKTX Stock Details VKTX Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$802K Sell
20,570
-445
-2% -$14.4K ﹤0.01% 2149
2026
Q1 		$684K Sell
21,015
-4,594
-18% -$148K ﹤0.01% 2019
2025
Q4 		$901K Buy
25,609
+281
+1% +$9.96K ﹤0.01% 1863
2025
Q3 		$666K Sell
25,328
-269
-1% -$8.03K ﹤0.01% 1994
2025
Q2 		$678K Sell
25,597
-3,252
-11% -$85.6K ﹤0.01% 1904
2025
Q1 		$697K Sell
28,849
-824
-3% -$26K ﹤0.01% 1803
2024
Q4 		$1.19M Buy
29,673
+9,321
+46% +$531K ﹤0.01% 1397
2024
Q3 		$1.29M Buy
20,352
+13,409
+193% +$787K ﹤0.01% 1340
2024
Q2 		$368K Buy
6,943
+1,237
+22% +$81.1K ﹤0.01% 1972
2024
Q1 		$468K Buy
+5,706
New +$254K ﹤0.01% 1830

Other funds holding VKTX

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Vanguard Capital Management
Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM
Vanguard Portfolio Management
Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM
Two Sigma Investments
Two Sigma Investments New York $138B AUM 41.87% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.89T AUM 35.08% 1-Year Est. Return
Ameriprise
Ameriprise Minneapolis, Minnesota $495B AUM 43.24% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.88T AUM 44.46% 1-Year Est. Return
American Century Companies
American Century Companies Kansas City, Missouri $226B AUM 44.75% 1-Year Est. Return

MML Investors Services's VKTX Position: Q2 2026 in Review

MML Investors Services reduced its Viking Therapeutics (VKTX) stake by 2.1% in Q2 2026, selling an estimated $14.4K and leaving 20,570 shares worth $802K. The position accounts for ﹤0.01% of the portfolio, ranked #2149.

MML Investors Services first reported a position in VKTX in Q1 2024 and has held it in 10 quarters since. The position peaked at $1.29M in Q3 2024. 432 funds tracked by Wall St. Rank hold VKTX as of Q2 2026.

  • MML Investors Services held 20,570 shares of Viking Therapeutics worth $802K as of Q2 2026.
  • MML Investors Services sold 445 Viking Therapeutics shares in Q2 2026, an estimated $14.4K.
  • Viking Therapeutics made up ﹤0.01% of MML Investors Services's portfolio in Q2 2026, its #2149 holding.
  • MML Investors Services first reported a position in Viking Therapeutics in Q1 2024 and has held it in 10 quarters since.
  • MML Investors Services's Viking Therapeutics position peaked at $1.29M in Q3 2024.
  • 432 funds tracked by Wall St. Rank held Viking Therapeutics as of Q2 2026.

Based on MML Investors Services's 13F filing for Q2 2026, filed 7 Aug 2026.